Aurum Biosciences appoints David Brennan as CEO
Glasgow-based novel biopharmaceuticals company Aurum Biosciences has appointed David Brennan as its new CEO. Brennan will help the company expand its global presence having recently served as interim Chief Executive of Aurum and Principal Clinical Physicist at the Queen Elizabeth University Hospital in Glasgow. Aurum develops breakthrough therapeutics and diagnostics in areas of unmet clinical […]